Skip to the page

Data / Drug companies / Labetalol hydrochloride

Labetalol hydrochloride: 43 companies and 140 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Labetalol hydrochloride is listed in the FDA National Drug Code Directory by 43 companies, with 140 products in commercial distribution. 135 of the products (96.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet; injection, and the newest product started marketing on October 19, 2026.

The request: Get every company that lists labetalol hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
43
Products
140
Generic (ANDA) products
135 (96.4%)
Application numbers
20
Routes
Oral, Intravenous
Brand names
Labetalol HCl in Sodium Chloride, Labetalol HCl in Dextrose, Labetalol HCL
openFDA record search
api.fda.gov

Companies that list labetalol hydrochloride

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
A-S Medication Solutions13tablet, film coatedGeneric drugs (ANDA)August 18, 2021
Bryant Ranch Prepack9tablet, film coatedGeneric drugs (ANDA)August 18, 2021
Hikma Pharmaceuticals USA Inc.8injection; injection, solutionNew drug applications (NDA)August 28, 2025
BluePoint Laboratories6tablet; tablet, film coatedGeneric drugs (ANDA)June 4, 2026
Bryant Ranch Prepack6tablet, film coatedGeneric drugs (ANDA)November 22, 2019
Cardinal Health 107, LLC6tablet, film coated; injection, solutionGeneric drugs (ANDA)May 6, 2025
Method Pharmaceuticals, LLC6tablet, film coatedGeneric drugs (ANDA)July 1, 2025
Advagen Pharma Ltd4tablet, film coatedGeneric drugs (ANDA)May 20, 2025
Biocon Pharma Inc.4tablet, film coatedGeneric drugs (ANDA)December 2, 2024
Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc.4tabletGeneric drugs (ANDA)May 15, 2026
NorthStar RxLLC4tablet; injection, solutionGeneric drugs (ANDA)March 19, 2026
American Health Packaging3tablet, film coatedGeneric drugs (ANDA)July 16, 2019
Baxter Healthcare Corporation3injection, solutionGeneric drugs (ANDA)January 26, 2021
Bryant Ranch Prepack3tablet, film coatedGeneric drugs (ANDA)November 22, 2019
Cadila Pharmaceuticals Limited3tablet, film coatedGeneric drugs (ANDA)May 29, 2018
Chartwell RX, LLC3tabletGeneric drugs (ANDA)February 22, 2020
Epic Pharma, LLC3tabletGeneric drugs (ANDA)September 30, 2021
Fosun Pharma USA Inc.3injectionGeneric drugs (ANDA)March 31, 2021
Golden State Medical Supply, Inc.3tablet, film coatedGeneric drugs (ANDA)June 20, 2018
Innogenix, Inc.3tablet, film coatedGeneric drugs (ANDA)February 8, 2021
Macleods Pharmaceuticals Limited3tablet, film coatedGeneric drugs (ANDA)September 23, 2025
Major Pharmaceuticals3tablet, film coatedGeneric drugs (ANDA)October 8, 2024
Remedyrepack Inc.3tablet, film coatedGeneric drugs (ANDA)October 2, 2024
Unichem Pharmaceuticals (USA), Inc.3tablet, film coatedGeneric drugs (ANDA)October 1, 2022
Zydus Lifesciences Limited3tablet, film coatedGeneric drugs (ANDA)December 5, 2017
Zydus Pharmaceuticals USA Inc.3tablet, film coatedGeneric drugs (ANDA)December 5, 2017
Caplin Steriles Limited2injection, solutionGeneric drugs (ANDA)February 14, 2025
Coupler LLC2tabletGeneric drugs (ANDA)October 19, 2026
Hospira, Inc.2injection, solutionGeneric drugs (ANDA)August 7, 2023
Mullan Pharmaceutical Inc.2injectionGeneric drugs (ANDA)December 5, 2025
NCS HealthCare of Ky, LLC DBA Vangard Labs2tablet, film coatedGeneric drugs (ANDA)May 27, 2021
Onesource Specialty Pharma Limited2injectionGeneric drugs (ANDA)February 27, 2026
Redpharm Drug2tablet, film coatedGeneric drugs (ANDA)August 18, 2021
St. Mary's Medical Park Pharmacy2tablet, film coatedGeneric drugs (ANDA)March 12, 2025
Amneal Pharmaceuticals LLC1injection, solutionGeneric drugs (ANDA)October 2, 2025
Armas Pharmaceuticals Inc.1injection, solutionGeneric drugs (ANDA)September 15, 2026
Civica, Inc.1injectionGeneric drugs (ANDA)November 21, 2019
Gland Pharma Limited1injection, solutionGeneric drugs (ANDA)April 19, 2012
Northwind Health Company, LLC1tablet, film coatedGeneric drugs (ANDA)April 25, 2023
NuCare Pharmaceuticals,Inc.1tablet, film coatedGeneric drugs (ANDA)May 27, 2021
Proficient Rx LP1tablet, film coatedGeneric drugs (ANDA)May 27, 2021
Proficient Rx LP1tablet, film coatedGeneric drugs (ANDA)August 3, 1998
Sagent Pharmaceuticals1injection, solutionGeneric drugs (ANDA)September 1, 2022

Dosage forms

Dosage formProductsShare
Tablet, film coated9366.4%
Tablet1812.9%
Injection1510.7%
Injection, solution1410%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)13596.4%
New drug applications (NDA)53.6%

Pharmacologic classes

ClassProducts
beta-Adrenergic Blocker140

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.